Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Gran Tierra Energy
GTE
$335M
| $615K | ﹤0.01% |
16,120
-1,452
| -8% | -$49.2K |
|
4027
MYR Group
MYRG
$5.25B
| $613K | ﹤0.01% |
18,803
+5,023
| +36% | +$177K |
|
4028
PUT
Energy Transfer Partners
ET
$72.1B
| $612K | ﹤0.01% |
35,100
-29,000
| -45% | -$515K |
|
4029
PUT
Okta
OKTA
$25.9B
| $612K | ﹤0.01% |
8,700
+2,400
| +38% | +$143K |
|
|
RDFN
4030
DELISTED
Redfin
RDFN
| $612K | ﹤0.01% |
32,709
-92,971
| -74% | -$1.97M |
|
|
LFC
4031
DELISTED
China Life Insurance Company Ltd.
LFC
| $611K | ﹤0.01% |
+53,679
| New | +$639K |
|
|
PVG
4032
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
| $611K | ﹤0.01% |
80,400
+22,400
| +39% | +$184K |
|
|
ECYT
4033
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $611K | ﹤0.01% |
34,406
+29,593
| +615% | +$508K |
|
|
DCOM
4034
DELISTED
Dime Community Bancshares
DCOM
| $611K | ﹤0.01% |
34,250
+22,861
| +201% | +$424K |
|
4035
CALL
Cooper Companies
COO
$14.9B
| $610K | ﹤0.01% |
8,800
+2,400
| +38% | +$154K |
|
4036
CALL
M&T Bank
MTB
$36.8B
| $609K | ﹤0.01% |
3,700
+2,500
| +208% | +$434K |
|
|
XLNX
4037
CALL
DELISTED
Xilinx Inc
XLNX
| $609K | ﹤0.01% |
7,600
+700
| +10% | +$51.2K |
|
|
EBIX
4038
PUT
DELISTED
Ebix Inc
EBIX
| $609K | ﹤0.01% |
7,700
+3,000
| +64% | +$239K |
|
4039
CALL
NewMarket
NEU
$8.65B
| $608K | ﹤0.01% |
1,500
+200
| +15% | +$80K |
|
4040
Veeco
VECO
$3.2B
| $607K | ﹤0.01% |
59,226
+41,416
| +233% | +$518K |
|
4041
CALL
AeroVironment
AVAV
$9.74B
| $606K | ﹤0.01% |
5,400
-3,000
| -36% | -$260K |
|
4042
Helios Technologies
HLIO
$2.73B
| $606K | ﹤0.01% |
11,062
+8,970
| +429% | +$454K |
|
4043
SFL Corp
SFL
$1.63B
| $606K | ﹤0.01% |
43,601
+27,979
| +179% | +$403K |
|
4044
Icahn Enterprises
IEP
$5.3B
| $605K | ﹤0.01% |
8,558
+6,466
| +309% | +$480K |
|
4045
PUT
KBR
KBR
$4.84B
| $604K | ﹤0.01% |
28,600
+3,400
| +13% | +$67.6K |
|
4046
American Coastal Insurance
ACIC
$462M
| $602K | ﹤0.01% |
26,937
+14,239
| +112% | +$294K |
|
4047
PUT
Cal-Maine
CALM
$3.87B
| $599K | ﹤0.01% |
12,400
-12,600
| -50% | -$603K |
|
|
HAPN
4048
Happen Inc
HAPN
$2.28B
| $599K | ﹤0.01% |
30,873
+18,531
| +150% | +$360K |
|
4049
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $599K | ﹤0.01% |
5,607
-1,008
| -15% | -$107K |
|
4050
PUT
Sanofi
SNY
$105B
| $599K | ﹤0.01% |
13,400
+9,000
| +205% | +$384K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.